Stryker Corp
NYSE:SYK

Watchlist Manager
Stryker Corp Logo
Stryker Corp
NYSE:SYK
Watchlist
Price: 365.06 USD 1.11%
Market Cap: 139.3B USD

During the last 3 months Stryker Corp insiders have not bought any shares, and sold 38.8m USD worth of shares. The stock price has dropped by 8% over this period (open performance analysis).

The last transaction was made on Feb 18, 2025 by Golston Allan C. (Director) , who sold 941.6k USD worth of SYK shares.

Last Transactions:
Golston Allan C.
Director
$-941.6k
Stryker Ronda E
Vice President, Chief Legal Officer
$-37.8m
Stiles Spencer S
Chairman and CEO
$-201.1k
Fink M Kathryn
Vice President, Chief Legal Officer
$-784.8k
Menon Viju
Vice President & Chief Information Officer
$-213k
Stryker Ronda E
Vice President, Chief Legal Officer
$-672.3k
Boehnlein Glenn S
Chief Financial Officer
$-6.7m
Fletcher Robert S
Vice President, Chief Compliance Officer
$-668.3k
Boehnlein Glenn S
Chief Financial Officer
$-3.3m
Berry William E Jr
Director
$-2.8m
Boehnlein Glenn S
Chief Financial Officer
$-3.3m
Stryker Ronda E
Vice President, Chief Legal Officer
$-10.6m
Golston Allan C.
Director
$-1.1m
Datar Srikant M.
$-149.1k
Berry William E Jr
Director
$-167.5k
Lobo Kevin
Chairman and Chief Executive Officer
$-9.4m
Datar Srikant M.
$-215.7k
Menon Viju
Vice President & Chief Information Officer
$-1.4m
Datar Srikant M.
$-214.7k
Datar Srikant M.
Director
$-139.3k
Datar Srikant M.
Director
$-286k
Golston Allan C.
Director
$-1.4m
Menon Viju
Vice President & Chief Information Officer
$-571.2k
Stryker Ronda E
Vice President, Chief Legal Officer
$-20.9m
Fletcher Robert S
Vice President, Chief Compliance Officer
$-850.6k
Pierce James Andrew
Vice President
$-111.2k
Boehnlein Glenn S
Chief Financial Officer
$-2.1m
Berry William E Jr
Director
$-924k
Fink M Kathryn
Vice President, Chief Legal Officer
$-919.4k
Datar Srikant M.
Director
$-119.3k
Lobo Kevin
Chairman and Chief Executive Officer
$-10.5m
Datar Srikant M.
Director
$-63.7k
View All Transactions

During the last 3 months Stryker Corp insiders have not bought any shares, and sold 38.8m USD worth of shares. The stock price has dropped by 8% over this period (open performance analysis).

The last transaction was made on Feb 18, 2025 by Golston Allan C. (Director) , who sold 941.6k USD worth of SYK shares.

Sold
0-3
months
38.8m USD
2
3-6
months
201.1k USD
1
6-9
months
8.3m USD
4
9-12
months
3.9m USD
2
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Stryker Corp
Insider Trading Chart

Stryker Corp
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Stryker Corp
Last Insider Transactions

Global
Insiders Monitor

Stryker Corp
Glance View

Economic Moat
Wide
Market Cap
139.2B USD
Industry
Health Care

Stryker Corporation, a pioneering force in the medical technology industry, traces its roots back to the innovative spirit of Dr. Homer Stryker, an orthopedic surgeon whose dissatisfaction with existing medical equipment spurred him to improve them. Founded in 1941, the company initially focused on new medical devices that addressed specific problems faced by healthcare practitioners. Over the decades, Stryker has evolved into a diversified powerhouse with a portfolio that spans a wide range of products, including joint replacements, surgical equipment, neurotechnology, and spine care solutions. This evolution came through strategic acquisitions and relentless innovation, allowing Stryker to meet the ever-increasing demands of a dynamic healthcare landscape. The company's business model thrives at the intersection of technology and healthcare. With their cutting-edge research and development capabilities, Stryker consistently pushes the envelope in creating sophisticated products that enhance patient outcomes. Revenue streams are predominantly generated from the sale of medical and surgical equipment as well as a myriad of implantable surgical devices used in orthopedic procedures. Stryker’s instruments and solutions are staples in hospitals and clinics worldwide, driven by their commitment to quality and efficacy. Additionally, the company's astute investments in advanced robotics and digital health technologies have positioned it well within the burgeoning field of precision medicine, providing lucrative opportunities to deepen its market entrenchment and expand its competitive edge.

SYK Intrinsic Value
300.7 USD
Overvaluation 18%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top